Genitourinary System Carcinoma — Trials

Genitourinary System Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

4,919 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,501
Recruiting: 783
Ph III recruiting: 85
Growth YoY: +18.1%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (758)

clinicaltrialsPublishedShowing 601–650 of 944 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07339267	A Study to Evaluate the Safety and Drug Levels of ASP5541 in Chinese Participants With Prostate Cancer	recruiting	Phase 1	12	Astellas Pharma Global Development, Inc.INDUSTRY	1	Feb 18, 2026	clinicaltrials
NCT05641935	Contrast-Enhanced Ultrasound Imaging for Diagnosing Recurrent Renal Cell Carcinoma (RCC) Post Ablation	recruiting	Phase 2	210	john eisenbreyOTHER	1	Feb 17, 2026	clinicaltrials